1. Home
  2. GNSS vs IMRX Comparison

GNSS vs IMRX Comparison

Compare GNSS & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNSS
  • IMRX
  • Stock Information
  • Founded
  • GNSS 1992
  • IMRX 2008
  • Country
  • GNSS United States
  • IMRX United States
  • Employees
  • GNSS N/A
  • IMRX 54
  • Industry
  • GNSS Consumer Electronics/Appliances
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNSS Consumer Staples
  • IMRX Health Care
  • Exchange
  • GNSS Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • GNSS 78.1M
  • IMRX 145.7M
  • IPO Year
  • GNSS N/A
  • IMRX 2021
  • Fundamental
  • Price
  • GNSS $1.96
  • IMRX $4.24
  • Analyst Decision
  • GNSS Strong Buy
  • IMRX Strong Buy
  • Analyst Count
  • GNSS 3
  • IMRX 4
  • Target Price
  • GNSS $5.33
  • IMRX $13.25
  • AVG Volume (30 Days)
  • GNSS 131.5K
  • IMRX 3.1M
  • Earning Date
  • GNSS 08-05-2025
  • IMRX 08-05-2025
  • Dividend Yield
  • GNSS N/A
  • IMRX N/A
  • EPS Growth
  • GNSS N/A
  • IMRX N/A
  • EPS
  • GNSS N/A
  • IMRX N/A
  • Revenue
  • GNSS $27,780,000.00
  • IMRX N/A
  • Revenue This Year
  • GNSS $91.14
  • IMRX N/A
  • Revenue Next Year
  • GNSS $75.44
  • IMRX N/A
  • P/E Ratio
  • GNSS N/A
  • IMRX N/A
  • Revenue Growth
  • GNSS N/A
  • IMRX N/A
  • 52 Week Low
  • GNSS $1.46
  • IMRX $1.00
  • 52 Week High
  • GNSS $4.04
  • IMRX $4.60
  • Technical
  • Relative Strength Index (RSI)
  • GNSS 70.78
  • IMRX 77.22
  • Support Level
  • GNSS $1.48
  • IMRX $3.31
  • Resistance Level
  • GNSS $1.85
  • IMRX $4.60
  • Average True Range (ATR)
  • GNSS 0.10
  • IMRX 0.43
  • MACD
  • GNSS 0.05
  • IMRX 0.12
  • Stochastic Oscillator
  • GNSS 98.11
  • IMRX 96.10

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: